News

Biovista is a biotechnology company that profiles novel uses and side effects for existing drugs using their mechanism of action. Biovista president Aris Persidis said they look forward

Net profit increased by 23% to DKK4,073m. Gross margin improved by 0.3% in local currencies, reflecting a favorable product mix development, but due to a negative currency effect,

Acelot’s new technology searches and mines directly in the space of molecules; something that has been thought of as too complex and slow in the past. Acelot said

Antula Healthcare, an independent over-the-counter (OTC) healthcare company in the Nordic markets, is the wholly owned Swedish subsidiary of HBI. The sale to Meda will allow HBI to

Under the agreement, Beactica will use its proprietary drug discovery platform, Sprint, to generate small-molecule lead compounds against undisclosed targets of therapeutic interest to Janssen. Reportedly, Janssen is

The expansion of the trial (currently ongoing in France) to two new countries will raise the total number of centers to over 40 and will help accelerate patient

CCR4 is one of 18 known chemokine receptors – proteins which bind molecules called chemokines to trigger various cellular responses. Developing antibodies to interfere with CCR4-expressing cells, such

Germany-based Huttlin produces specialist drying and granulation equipment from powder to the production of pharmaceuticals. The UK based Manesty specializes in tablet presses and coaters. Bosch Packaging Technology,

Impax, a manufacturer of both brand and generic drug products, has implemented SAP to derive the benefits of tighter integration of global processes, accelerate the adoption of best